The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance—study protocol for a randomized 4-way balanced cross-over trial

BACKGROUND: Asthma and/or airway hyper-responsiveness (AHR) are common in elite endurance athletes with a high prevalence rate of beta-2 adrenoreceptor (beta-2) agonists use. Nevertheless, there are data on dose-dependent ergogenic effects of beta-2 agonists suggesting increased muscle strength, end...

Descripción completa

Detalles Bibliográficos
Autores principales: Zügel, Martina, Bizjak, Daniel A., Nussbaumer, Dorle, Winkert, Kay, Takabayashi, Kensuke, Kirsten, Johannes, Washington, Mickel, Treff, Gunnar, Dreyhaupt, Jens, Steeb, Luise, Diel, Patrick, Parr, Maria Kristina, Steinacker, Jürgen M., Persch, Hasema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665595/
https://www.ncbi.nlm.nih.gov/pubmed/34895300
http://dx.doi.org/10.1186/s13063-021-05862-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665595/
https://www.ncbi.nlm.nih.gov/pubmed/34895300
http://dx.doi.org/10.1186/s13063-021-05862-w

Ejemplares similares